Navigation Links
Pieris and Pepscan to Identify GPCR-Specific Anticalins(R) Using CLIPS(TM) Protein Mimicry Technology
Date:10/30/2007

FREISING-WEIHENSTEPHAN, Germany, October 30 /PRNewswire/ -- Pieris AG (Munich, Germany) and Pepscan Therapeutics (Lelystad, Netherlands) today announced the commencement of a research collaboration aimed at identifying Anticalins(R) specific for G-Protein Coupled Receptors (GPCRs) and their development as therapeutic candidates.

Pieris has pioneered Anticalins(R) as next generation targeted therapeutics with clear advantages over monoclonal antibodies, while Pepscan has developed CLIPS(TM) technology to yield immunogens targeting functional epitopes on proteins. Through this newly announced collaboration, the companies aim to combine and apply their respective technologies to the discovery and development of novel Anticalins(R) able to modulate GPCR function in disease.

GPCRs form one of the most important classes of drug targets, yet for many of these receptors, no pharmacologically active small molecule drugs have been identified. Biotherapeutics provide an intriguing alternative if they can be selectively targeted to functional epitopes, yet monoclonal antibodies modulating GPCR action have to date proven technically challenging. Pepscan's CLIPS(TM) technology has the distinct advantage of selectively identifying functional mimics of the extracellular portions of GPCRs which are fundamental in biology. Such mimics will be used by Pieris to select Anticalins(R) with disease modifying potential.

"Pieris has successfully isolated and characterised high potency Anticalins(R) against structurally diverse functional epitopes on a wide range of medically relevant proteins", said Dr Andreas Hohlbaum, Director of Science and Preclinical Development at Pieris. "Incorporating Pepscan's CLIPS(TM) technology into our selection and screening process now allows us to discover Anticalins(R) with high affinity and selectivity for specific GPCRs".

Dr Rob Meloen, Chief Scientific Officer of Pepscan Therapeutics commented: "Functional binding proteins
'/>"/>

SOURCE Pieris AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
2. Now you can identify Sperm and Egg donors
3. Identifying Predictors Of Anthrax
4. Identifying The Risks Of Developing Schizophrenia
5. Researchers identify the early makers of Neonatal Sepsis
6. Researchers Identify Gene Connected To Bipolar Disorder
7. Blood test may identify ovarian cancer
8. Identifying bacteria made amiable
9. Latest device for identifying Melanomas
10. Identifying brain lesions with impaired consciousness
11. Identifying Virus Found To Be Essential for HIV Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team in Hong ... This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce but ... this initiative Cotton explained, “We send anything between 300 and 600 pieces of paper per ...
(Date:7/7/2015)... ... ... Healthpointe is proud to announce the addition of Dr. Pedro S. ... will be evaluating and treating patients with orthopedic complaints, such as lumbar back pain ... Science in Biology from the University of the East, Manila, Dr. Alupay earned his ...
(Date:7/7/2015)... York, NY (PRWEB) , ... July 07, 2015 , ... ... a new convenient online destination for HSA holders. HSAstore.com makes it simple to use, ... to help consumers better understand their accounts. , According to a ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... creative design firm, today announced that TimberNook ( http://www.timbernook.com/ ) has ... campaign, content strategy, and marketing launch package for new camp providers. TimberNook ...
(Date:7/7/2015)... Ann Arbor, MI and Wellesley, MA (PRWEB) , ... ... ... and the National Institute of Whole Health (NIWH) have jointly announced ... credentialed health professionals addressing unsolved, chronic medical case studies. The study will be ...
Breaking Medicine News(10 mins):Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3
... Groff will perform a PPP laser procedure on The ... listings for airtime. SANTA CLARA, Calif., March 10 ... laser, light-based and radio-frequency devices for surgical, aesthetic, and ... be featured on The Doctors national television show on ...
... silent killer, , , TUESDAY, March 10 (HealthDay News) -- Used ... be effective in detecting ovarian cancer in its early and ... method could become a new standard in the fight against ... "It appears to be an approach that may be workable," ...
... The Agency for Healthcare Research and Quality today released ... children who are in a hospital or a school ... consists of guidelines to assist pediatric hospitals in converting ... community hospital emergency departments provide care for large numbers ...
... leading matchmaker between military veterans and civilian employers, ... to find military health care workers who are ... The program, called Health Care Advertising Packages (HCAPs), ... difficulty of finding qualified health care workers. ...
... Inc. (Nasdaq: MLAB ), a supplier of instruments ... announced the appointment of Dr. John J. Sullivan to the ... who has been the CEO since founding the company in ... his positions of CEO and Treasurer, but will retain his ...
... Scheduled for Today - Tuesday, March 10, 2009 at ... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) reported ... ended December 31, 2008, and provided an update on ... the quarter and year ended December 31, 2008, as ...
Cached Medicine News:Health News:Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure 2Health News:Combo of Tests Might Spot Ovarian Cancer Early 2Health News:Combo of Tests Might Spot Ovarian Cancer Early 3Health News:AHRQ Issues Recommendations for Safeguarding Children During Public Health Emergencies 2Health News:AHRQ Issues Recommendations for Safeguarding Children During Public Health Emergencies 3Health News:New G.I. Jobs Program Provides Hospitals a Cost Effective Way to Find Prior Military Health Care Workers 2Health News:Mesa Labs Announces the Appointment of New CEO 2Health News:Mesa Labs Announces the Appointment of New CEO 3Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 2Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 3Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 4Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 5Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 6Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 7Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 8Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 9Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 10Health News:Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status 11
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
(Date:7/7/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... offering of 32,000,000 units. Each unit consists of one share ... purchase one share of common stock at a purchase ... units in the offering would result in them beneficially ...
(Date:7/7/2015)... July 7, 2015 Oasmia ... of drugs within human and veterinary oncology, today ... in the United States , ... leading companion animal therapeutic.      (Logo: ... ) , Paccal Vet-CA1 was ...
Breaking Medicine Technology:Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... , , , ... service Contract Research Organization (CRO) founded in India, today announced the ... Application Suite (OLSAS) by going live with Oracle Siebel Clinical Trial ... , "We are excited to have the rollout of ...
... Aug. 5 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... a New Drug Submission (NDS) with the Therapeutic Products ... the antidepressant trazodone. , "We are pleased to file ... R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. ...
Cached Medicine Technology:SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 3
For the quantitative in vitro determination of Lactate Dehydrogenase (LD) in serum and plasma....
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
Medicine Products: